James E. Dahlman
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Molecular Biology top 1%
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- CRISPR and Genetic Engineering
Papers in
-
- RNA Interference and Gene Delivery 56
- Advanced biosensing and bioanalysis techniques 28
- CRISPR and Genetic Engineering 12
- Lipid Membrane Structure and Behavior 8
- RNA Research and Splicing 4
-
- MicroRNA in disease regulation 13
- Co-authors
- Róbert Langer (23 shared papers)Kalina Paunovska (25 shared papers)David Loughrey (22 shared papers)Mark W. Tibbitt (2 shared papers)Daniel G. Anderson (22 shared papers)Melissa P. Lokugamage (24 shared papers)Cory D. Sago (15 shared papers)Avi Schroeder (5 shared papers)
- Journals
- Nano Letters (6 papers)Advanced Materials (5 papers)Proceedings of the National Academy of Sciences (5 papers)Nature Communications (4 papers)Nature Nanotechnology (4 papers)
- Partner nations
- United StatesNetherlandsIsrael
In The Last Decade
James E. Dahlman
80 papers receiving 8.4k citations
James E. Dahlman's Hit Papers
Peers
Comparison fields: 5 of 155
- Biomaterials 1.6k
- Molecular Biology 5.8k
- Cancer Research 800
- Immunology 917
- Pharmaceutical Science 267
Countries citing papers authored by James E. Dahlman
This map shows the geographic impact of James E. Dahlman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Dahlman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Dahlman more than expected).
Fields of papers citing papers by James E. Dahlman
This network shows the impact of papers produced by James E. Dahlman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Dahlman. The network helps show where James E. Dahlman may publish in the future.
Co-authors
The 25 scholars most cited alongside James E. Dahlman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Treating metastatic cancer with nanotechnology Hit paper breakdown → | 2011 | 1016 |
| 2 | Drug delivery systems for RNA therapeutics Hit paper breakdown → | 2022 | 950 |
| 3 | Emerging Frontiers in Drug Delivery Hit paper breakdown → | 2016 | 844 |
| 4 | In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight Hit paper breakdown → | 2014 | 514 |
| 5 | Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs Hit paper breakdown → | 2021 | 391 |
| 6 | Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart Failure Hit paper breakdown → | 2016 | 335 |
| 7 | 2017 | 268 | |
| 8 | 2018 | 259 | |
| 9 | 2018 | 212 | |
| 10 | 2014 | 211 | |
| 11 | 2015 | 207 | |
| 12 | 2019 | 176 | |
| 13 | 2016 | 173 | |
| 14 | 2011 | 161 | |
| 15 | 2021 | 142 | |
| 16 | Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo Hit paper breakdown → | 2022 | 142 |
| 17 | 2018 | 138 | |
| 18 | 2019 | 136 | |
| 19 | 2015 | 133 | |
| 20 | 2015 | 123 |
About James E. Dahlman
James E. Dahlman is a scholar working on Molecular Biology, Cancer Research, Immunology, Genetics and Infectious Diseases, having authored 87 papers that have together received 8.6k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (56 papers), Advanced biosensing and bioanalysis techniques (28 papers), MicroRNA in disease regulation (13 papers), CRISPR and Genetic Engineering (12 papers), Lipid Membrane Structure and Behavior (8 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Platelet Disorders and Treatments (4 papers) and RNA Research and Splicing (4 papers). The work is most often cited by research in Biomaterials (1.6k citations), Molecular Biology (5.8k citations), Cancer Research (800 citations), Immunology (917 citations) and Pharmaceutical Science (267 citations). James E. Dahlman has collaborated with scholars based in United States, Netherlands and Israel. Frequent co-authors include Róbert Langer, Kalina Paunovska, David Loughrey, Mark W. Tibbitt, Daniel G. Anderson, Melissa P. Lokugamage, Cory D. Sago, Avi Schroeder, Tyler Jacks and Daniel A. Heller. Their work appears in journals such as Nano Letters, Advanced Materials, Proceedings of the National Academy of Sciences, Nature Communications and Nature Nanotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.